To determine if levels of DNA methylation modifiers are deregulated in human PTCL, we further analyzed RNA-seq data and found that DNMT3A was significantly reduced in all tumors when compared to either CD4 + or CD8 + normal T-cells from peripheral blood (Fig. 4A). The gene discussed is CD8A; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.